Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RADAR: Renal Denervation Using Dehydrated Alcohol Injection in Uncontrolled Hypertension
NCT07083765Phase 3Not yet recruiting
- Sponsor
- Ablative Solutions
- Start
- Oct 2026
- Primary completion
- May 2028
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of ethanol in hypertension (HTN), sponsored by Ablative Solutions. Planned start Oct 2026; status: not yet recruiting.
02
Drugs
ethanol
03
Conditions
hypertension (HTN)
Beyond the preview
Go deeper on NCT07083765.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07083765.